Navigation Links
Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
Date:11/12/2008

ORANGE COUNTY, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Charlie Slacik, Beckman Coulter's senior vice president and chief financial officer, will present at the Lazard Capital Markets 5th Annual Healthcare Conference on Tuesday, November 18, 2008 at 4:40 p.m. (ET).

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The live webcast of Beckman Coulter's presentation can be accessed by visiting their website at http://www.beckmancoulter.com. To access the webcast select "go to IR" under "Investor Relations" and find the event listed under "What's Ahead." The webcast will be archived on the company's website for future on-demand replay.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78 percent of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Contact: Cynthia Skoglund

(714) 773-8213

Manager, Investor Relations


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
2. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
3. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
4. Beckman Coulter Investor Events Second Half of 2008
5. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
6. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
7. Beckman Coulter Announces Second Quarter 2008 Results
8. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
9. Upcoming Beckman Coulter Investor Events Second Half of 2008
10. Beckman Coulter to Present at Upcoming Healthcare Conferences
11. Beckman Coulter Announces First Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ire-FirstCall/ -- Stallergenes has been,granted Eu...s and children,through a Mutual Recognition Proced...as been marketed, was the reference Member state. ..., Belgium, Bulgaria, Cyprus, the,Czech Republic, E... Italy,Latvia, Lithuania, Luxembourg, Malta, the ...
(Date:11/25/2009)...re/ -- Biotech firm Replikins Ltd., which has anal...ndemic through the prediction, outbreak, and progr... latest biochemical analysis of the virus. The new... Flu") virus has dropped from its peak of 3.7 (s.d...spring of 2009 to resting non-epidemic levels this...
(Date:11/25/2009)...Newswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a l...ed today that it executed,a joint venture (JV) agr...ology Co., Ltd. (Sinovac Dalian). The JV will rese... vaccines. Sinovac will contribute its expertise,a...rld-class vaccines; the,other party will bring its...
(Date:11/24/2009)...e-FirstCall/ -- IES (Nasdaq: IESC ), a leading na...ystems and services for the commercial, industrial... commercial business group has been awarded a cont...rical systems for the Level 4 bio-safety lab (BSL-...esearch Institute of Infectious Diseases (USAMRIID...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
... Company will Share Sneak Peek at S...al Trial , New York (PRWE...Histogen, Inc., a regenerative medicine company de...n fibroblasts grown under embryonic conditions, wi...em Cell Summit in New York. Dr. Naughton will be p...
...Feb. 14 /PRNewswire-Asia-FirstCall/ -- Yongye Biot... YGYB; "Yongye" or the "Company"), a leading devel...ants and animals, located in the People,s Republic...gement will host a conference call and webcast in ... of the Company followed by a question and answer ...
... Feb. 13 On February 10, 2009, NeoStem, Inc. (NYS...ce from the NYSE Alternext US (the "Alternext") in...h Section 704 of the Alternext Company Guide (the ...meetings of its shareholders annually. , , On No...planned to hold a shareholder meeting to obtain ap...
Other Biology Technology:Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit 2Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit 3Yongye Biotechnology to Host 'Virtual Retail Road Show' to Provide Overview of the Company in English and Mandarin 2Yongye Biotechnology to Host 'Virtual Retail Road Show' to Provide Overview of the Company in English and Mandarin 3Yongye Biotechnology to Host 'Virtual Retail Road Show' to Provide Overview of the Company in English and Mandarin 4NeoStem Receives Notice of Noncompliance from NYSE Alternext US 2
(Date:11/26/2009)...009) Whitehead researchers have developed a new t...specific genes and proteins used by pathogens, acc...man cell cultures genes are present in two copies:...ther. Gene inactivation by mutation is therefore i...he second copy usually remains active and takes ov...
(Date:11/25/2009)...he stomach, may be used to boost resistance to, or...e School of Medicine researchers report in a study...uroscience . , Parkinson,s disease is caused by ...he midbrain known as the substantia nigra, which i...oduction of dopamine in late-stage Parkinson,s cau...
(Date:11/25/2009)...Soil is the linchpin of the environment, where atm...that, many students see soil as "just dirt" a pla...educators are challenged with the task of helping ...ortance of soil in the environment. , A collabo...eachers at University of Nebraska-Lincoln, Oregon ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Moms to Be Need Facts on Pain Control 56315 1Moms to Be Need Facts on Pain Control 56315 2TrueShred Earns Industrys Highest Security Certification 56311 1Women Urged Not to Drink While Pregnant 56308 1Women Urged Not to Drink While Pregnant 56308 2Women Urged Not to Drink While Pregnant 56308 3
...s have developed a way to synthesize a cancer-kill... learn how it works. , Derived from a fungus disco... the chemical tricks certain cancer cells into sui... 2000, scientists in Japan discovered that this co...rototype anticancer agent, but no one has been abl...
...California, San Diego (UCSD) School of Medicine sh...f liver cell death and renewal. , The research, ap...ublication in the journal Proceedings of the Natio...e of JNK1-mediated cell death and compensatory pro... professor pharmacology in UCSD¡¦s Laboratory of G...
...ubjects shows that HIV in the brain and central ne...t lives in the blood and peripheral tissues. , Mo...dy subjects was correlated with the presence of a ... The study appears in the July 2006 issue of Brain...earch associate at SFVAMC and a postdoctoral fello...
Other Biology News:New lab technique churns out fungus' potential cancer fighter 2Cycles of cell death, proliferation key to liver cancer 2Viral genetic differences are possible key to HIV dementia 2Viral genetic differences are possible key to HIV dementia 3
DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
...Description: Topoisomerase I relaxes both positive...reakage and rejoining of phosphodiester bonds (1,2...allows molecules to be differentiated by a single ...somerase I is active in the absence of Mn 2+ and ...
...ning a clone of the human Topoisomerase II gene. ...gical state of nucleic acids by passing an intact ...s a separate DNA helix (1,2) . As a result of its ...can relax negatively or positively supercoiled DNA...
...yzes the template-directed polymerization of nucle...ymerase I possesses a 3?5 exonuclease activity or ...te during DNA replication, and also contains a 5?3... replace nucleotides in the growing strand of DNA ...
Biology Products: